The Living Guidelines: STEMI Recommendations for Angiotensin Receptor Blockers Therapy Polling Results for CLASS I Guidelines

Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, WikiDoc suggests that the following classification scheme be used. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.

Class I Guidelines
1. Use of angiotensin receptor blockers is recommended in patients who are intolerant of ACE inhibitors and have Heart Failure or have had a Myocardial Infarction with LVEF ≤40%. Class I (Level of Evidence: A)

 AHA / ACC 2007 STEMI Guidelines Angiotensin Receptor Blockers Therapy Class I Recommendation 1 should be: CLASS I CLASS IIa CLASS IIb CLASS III

2. It is beneficial to use angiotensin receptor blocker therapy in other patients who are ACE-inhibitor intolerant and have hypertension. Class I (Level of Evidence: B)

 AHA / ACC 2007 STEMI Guidelines Angiotensin Receptor Blockers Therapy Class I Recommendation 2 should be: CLASS I CLASS IIa CLASS IIb CLASS III